| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8787532 | Journal of Thoracic Oncology | 2018 | 21 Pages | 
Abstract
												In this analysis, we have noted significant differences in radiosensitivity on the basis of primary histologic type of lung metastases and have modeled the biologically effective dose necessary to optimize local control. This study suggests that primary histologic type may be an additional factor to consider in selection of SBRT dose to the lung and that dose personalization may be feasible.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Oncology
												
											Authors
												Kamran A. MD, Jacob G. MD, John A. MD, Arash O. MD, G. Daniel MD, PhD, Bradford A. MD, Jimmy J. MD, PhD, Anders E. PhD, Eric A. PhD, Steven A. PhD, Thomas J. MD, Javier F. MD, 
											